Cerebroside-β-Glucosidase Encapsulation in Liposomes for Gaucher's Disease Treatment Revisited

[1]  Gregory Gregoriadis,et al.  Dehydration-Rehydration Vesicles: A Simple Method for High Yield Drug Entrapment in Liposomes , 1984, Bio/Technology.

[2]  S. Raghavan,et al.  Leukocyte beta-glucosidase in homozygotes and heterozygotes for Gaucher disease. , 1980, American journal of human genetics.

[3]  J. Chesebro,et al.  Platelet Deposition In Extracardiac Conduits In Humans: A Noninvasive Quantification , 1981, Thrombosis and Haemostasis.

[4]  G. Gregoriadis,et al.  TREATMENT OF GAUCHER'S DISEASE WITH LIPOSOME-ENTRAPPED GLUCOCEREBROSIDE: β-GLUCOSIDASE , 1977, The Lancet.

[5]  Y. Barenholz.  CHAPTER 7.1 – Design of liposome-based drug carriers: From basic research to application as approved drugs , 1998 .

[6]  A. Saven,et al.  Enzyme replacement therapy for Gaucher disease. , 1991, Blood.

[7]  L. Vroman,et al.  Interaction of high molecular weight kininogen, factor XII, and fibrinogen in plasma at interfaces. , 1980, Blood.

[8]  Y. Barenholz,et al.  Delivery of cytokines by liposomes. III. Liposome-encapsulated GM-CSF and TNF-alpha show improved pharmacokinetics and biological activity and reduced toxicity in mice. , 1997, Journal of immunotherapy.

[9]  J. Brash,et al.  Effect of Plasma Dilution on Adsorption of Fibrinogen to Solid Surfaces , 1984, Thrombosis and Haemostasis.

[10]  R. Brady,et al.  Replacement therapy for inherited enzyme deficiency. Use of purified glucocerebrosidase in Gaucher's disease. , 1974, The New England journal of medicine.

[11]  R. Brady,et al.  Enhanced macrophage uptake of synthetically glycosylated human placental beta-glucocerebrosidase. , 1982, The Journal of biological chemistry.